Short answer
Oscar Health, Inc. (OSCR) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $6M (up 32.1% year over year) with net income of $679M.
Q1 2026 key financials · XBRL
- Revenue
- $6M
- +32.1% YoY
- Net income
- $679M
- +146.7% YoY
- Operating margin
- 12313.5%
- EPS (diluted)
- $2.07
- +125.0% YoY
Source: XBRL data from the Oscar Health, Inc. (OSCR) Q1 2026 10-Q on SEC EDGAR. USD.
Oscar Health, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $4,647.2M, up $1,600.9M or 53% YoY
- Earnings from operations $704.1M vs $297.1M YoY
- MLR 70.5% vs 75.4%; SG&A ratio 15.2% vs 15.8% YoY
- Individual and Small Group membership 3.17M vs 2.02M; Cigna+Oscar membership worst at zero
- Health Insurance Subsidiaries cash, equivalents and investments $7.8B vs $5.1B at December 31, 2025
- Headwinds: eAPTC expiration, tighter enrollment rules, OBBBA, and proposed 100% pharmaceutical tariffs
Risk Factors
- No material changes to 2025 Form 10-K risk factors disclosed
- New $11.9 million CEO stock purchase for 1,000,000 Class A shares
- New $1.7 billion credit agreement dated February 6, 2026
- CFO 10b5-1 plan permits sales of up to 210,000 Class A shares through June 26, 2027
- CTO 10b5-1 plans permit sales of up to 1,075,000 Class B shares through June 30, 2027
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Oscar Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.